Sefacor
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Mercer Rd, Natick, Massachusetts, 0176...Phone Number
(617) 283-2975Website
www.sefacor.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
About Sefacor
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sefacor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sefacor, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sefacor had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sefacor
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sefacor recently announced quarterly report
Funding: Get notified immidiatlly once Sefacor has new funding data
Check out if Sefacor is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Sefacor has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sefacor launches new products
Recommended Actions
Find VP level buyers at Sefacor
Find more new buyers
Company Profile Activity
Activity Insights
Sefacor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sefacor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sefacor.
Sefacor Tech Stack
A closer look at the technologies used by Sefacor
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sefacor
Sefacor is a biopharmaceutical company focused on developing innovative treatments for solid tumors, particularly glioblastoma. Their proprietary drug, SFCR001, aims to improve clinical outcomes for glioma patients by targeting biochemical pathways disrupted in cancer cells. With promising preclinical and clinical results, Sefacor is positioned to... Read More
